ATE326862T1 - Oligosaccharide enthaltende ernährungszusammensetzungen - Google Patents
Oligosaccharide enthaltende ernährungszusammensetzungenInfo
- Publication number
- ATE326862T1 ATE326862T1 AT98912118T AT98912118T ATE326862T1 AT E326862 T1 ATE326862 T1 AT E326862T1 AT 98912118 T AT98912118 T AT 98912118T AT 98912118 T AT98912118 T AT 98912118T AT E326862 T1 ATE326862 T1 AT E326862T1
- Authority
- AT
- Austria
- Prior art keywords
- lacto
- compositions containing
- nutritional compositions
- containing oligosaccharides
- fucopentaose
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 2
- 235000016709 nutrition Nutrition 0.000 title abstract 2
- 229920001542 oligosaccharide Polymers 0.000 title abstract 2
- 150000002482 oligosaccharides Chemical class 0.000 title abstract 2
- 229940062827 2'-fucosyllactose Drugs 0.000 abstract 1
- HWHQUWQCBPAQQH-UHFFFAOYSA-N 2-O-alpha-L-Fucosyl-lactose Natural products OC1C(O)C(O)C(C)OC1OC1C(O)C(O)C(CO)OC1OC(C(O)CO)C(O)C(O)C=O HWHQUWQCBPAQQH-UHFFFAOYSA-N 0.000 abstract 1
- HWHQUWQCBPAQQH-BWRPKUOHSA-N 2-fucosyllactose Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O HWHQUWQCBPAQQH-BWRPKUOHSA-N 0.000 abstract 1
- AUNPEJDACLEKSC-ZAYDSPBTSA-N 3-fucosyllactose Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)O[C@H](CO)[C@@H]1O AUNPEJDACLEKSC-ZAYDSPBTSA-N 0.000 abstract 1
- WJPIUUDKRHCAEL-UHFFFAOYSA-N 3FL Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(CO)OC(O)C1O WJPIUUDKRHCAEL-UHFFFAOYSA-N 0.000 abstract 1
- TVVLIFCVJJSLBL-SEHWTJTBSA-N Lacto-N-fucopentaose V Chemical compound O[C@H]1C(O)C(O)[C@H](C)O[C@H]1OC([C@@H](O)C=O)[C@@H](C(O)CO)O[C@H]1[C@H](O)[C@@H](OC2[C@@H](C(OC3[C@@H](C(O)C(O)[C@@H](CO)O3)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](O)[C@@H](CO)O1 TVVLIFCVJJSLBL-SEHWTJTBSA-N 0.000 abstract 1
- LKOHREGGXUJGKC-UHFFFAOYSA-N Lactodifucotetraose Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)OC2CO)OC2C(C(O)C(O)C(C)O2)O)OC(CO)C(O)C1O LKOHREGGXUJGKC-UHFFFAOYSA-N 0.000 abstract 1
- AXQLFFDZXPOFPO-UHFFFAOYSA-N UNPD216 Natural products O1C(CO)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(=O)C)C1OC(C1O)C(O)C(CO)OC1OC1C(O)C(O)C(O)OC1CO AXQLFFDZXPOFPO-UHFFFAOYSA-N 0.000 abstract 1
- SNFSYLYCDAVZGP-UHFFFAOYSA-N UNPD26986 Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(OC(O)C(O)C2O)CO)OC(CO)C(O)C1O SNFSYLYCDAVZGP-UHFFFAOYSA-N 0.000 abstract 1
- FZIVHOUANIQOMU-YIHIYSSUSA-N alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]([C@H](O[C@@H]3[C@H]([C@H](O[C@@H]4[C@H](OC(O)[C@H](O)[C@H]4O)CO)O[C@H](CO)[C@@H]3O)O)O[C@H](CO)[C@H]2O)NC(C)=O)O[C@H](CO)[C@H](O)[C@@H]1O FZIVHOUANIQOMU-YIHIYSSUSA-N 0.000 abstract 1
- LKOHREGGXUJGKC-GXSKDVPZSA-N alpha-L-Fucp-(1->3)-[alpha-L-Fucp-(1->2)-beta-D-Galp-(1->4)]-beta-D-Glcp Chemical compound C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]2O[C@@H]2[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]2O[C@@H]2O[C@@H](C)[C@@H](O)[C@@H](O)[C@@H]2O)[C@@H](O)[C@H](O)[C@@H]1O LKOHREGGXUJGKC-GXSKDVPZSA-N 0.000 abstract 1
- CMQZRJBJDCVIEY-JEOLMMCMSA-N alpha-L-Fucp-(1->3)-[beta-D-Galp-(1->4)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](CO)O[C@@H](O[C@@H]2[C@H]([C@H](O[C@@H]3[C@H](OC(O)[C@H](O)[C@H]3O)CO)O[C@H](CO)[C@@H]2O)O)[C@@H]1NC(C)=O CMQZRJBJDCVIEY-JEOLMMCMSA-N 0.000 abstract 1
- DUKURNFHYQXCJG-JEOLMMCMSA-N alpha-L-Fucp-(1->4)-[beta-D-Galp-(1->3)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](NC(C)=O)[C@H](O[C@@H]2[C@H]([C@H](O[C@@H]3[C@H](OC(O)[C@H](O)[C@H]3O)CO)O[C@H](CO)[C@@H]2O)O)O[C@@H]1CO DUKURNFHYQXCJG-JEOLMMCMSA-N 0.000 abstract 1
- AXQLFFDZXPOFPO-UNTPKZLMSA-N beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp Chemical compound O([C@@H]1O[C@H](CO)[C@H](O)[C@@H]([C@H]1O)O[C@H]1[C@@H]([C@H]([C@H](O)[C@@H](CO)O1)O[C@H]1[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O1)O)NC(=O)C)[C@H]1[C@H](O)[C@@H](O)[C@H](O)O[C@@H]1CO AXQLFFDZXPOFPO-UNTPKZLMSA-N 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- FZIVHOUANIQOMU-UHFFFAOYSA-N lacto-N-fucopentaose I Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(OC3C(C(OC4C(OC(O)C(O)C4O)CO)OC(CO)C3O)O)OC(CO)C2O)NC(C)=O)OC(CO)C(O)C1O FZIVHOUANIQOMU-UHFFFAOYSA-N 0.000 abstract 1
- FKADDOYBRRMBPP-UHFFFAOYSA-N lacto-N-fucopentaose II Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(C)=O)C(OC2C(C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C2O)O)OC1CO FKADDOYBRRMBPP-UHFFFAOYSA-N 0.000 abstract 1
- CMQZRJBJDCVIEY-UHFFFAOYSA-N lacto-N-fucopentaose III Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(CO)OC(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)C1NC(C)=O CMQZRJBJDCVIEY-UHFFFAOYSA-N 0.000 abstract 1
- IEQCXFNWPAHHQR-UHFFFAOYSA-N lacto-N-neotetraose Natural products OCC1OC(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)C(NC(=O)C)C(O)C1OC1OC(CO)C(O)C(O)C1O IEQCXFNWPAHHQR-UHFFFAOYSA-N 0.000 abstract 1
- USIPEGYTBGEPJN-UHFFFAOYSA-N lacto-N-tetraose Natural products O1C(CO)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(=O)C)C1OC1C(O)C(CO)OC(OC(C(O)CO)C(O)C(O)C=O)C1O USIPEGYTBGEPJN-UHFFFAOYSA-N 0.000 abstract 1
- 229940062780 lacto-n-neotetraose Drugs 0.000 abstract 1
- RBMYDHMFFAVMMM-PLQWBNBWSA-N neolactotetraose Chemical compound O([C@H]1[C@H](O)[C@H]([C@@H](O[C@@H]1CO)O[C@@H]1[C@H]([C@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@H](CO)[C@@H]1O)O)NC(=O)C)[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O RBMYDHMFFAVMMM-PLQWBNBWSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S426/00—Food or edible material: processes, compositions, and products
- Y10S426/801—Pediatric
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Pediatric Medicine (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Dairy Products (AREA)
- Jellies, Jams, And Syrups (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/829,157 US6045854A (en) | 1997-03-31 | 1997-03-31 | Nutritional formulations containing oligosaccharides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE326862T1 true ATE326862T1 (de) | 2006-06-15 |
Family
ID=25253688
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98912118T ATE326862T1 (de) | 1997-03-31 | 1998-03-30 | Oligosaccharide enthaltende ernährungszusammensetzungen |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US6045854A (de) |
| EP (1) | EP0975235B2 (de) |
| JP (2) | JP4863236B2 (de) |
| AT (1) | ATE326862T1 (de) |
| CA (1) | CA2285065C (de) |
| DE (1) | DE69834633T3 (de) |
| DK (1) | DK0975235T4 (de) |
| ES (1) | ES2265161T5 (de) |
| MX (1) | MX210206B (de) |
| NO (1) | NO315682B1 (de) |
| PT (1) | PT975235E (de) |
| WO (1) | WO1998043494A1 (de) |
Families Citing this family (88)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19701382A1 (de) * | 1997-01-16 | 1998-07-23 | Nutricia Nv | Kohlenhydratmischung |
| US6329170B1 (en) * | 1999-04-23 | 2001-12-11 | Northwest Hospital | Nucleic acids and proteins of a rat ganglioside GM1-specific α1→2fucosyltransferase and uses thereof |
| DE19958985A1 (de) * | 1999-12-07 | 2001-06-13 | Nutricia Nv | Oligosaccharidmischung |
| EP1062873A1 (de) * | 1999-12-13 | 2000-12-27 | N.V. Nutricia | Verbessertes Säuglingsnährpräparat, Eiweisshydrolysat zur Verwendung in solchem Säuglingsnährpräparat, und Verfahren zur Herstellung solches Hydrolysates |
| EP1372641A4 (de) | 2001-03-05 | 2004-08-25 | Stephen P Ernest | Enterale formulierung |
| DE10147100A1 (de) * | 2001-09-25 | 2003-04-17 | Numico Res B V | Antiinfektive Kohlenhydrate |
| DE10204000A1 (de) * | 2002-02-01 | 2003-08-14 | Nutricia Nv | Sialysierte Kohlenhydrate |
| US7977098B2 (en) * | 2002-05-31 | 2011-07-12 | Children's Hospital Medical Center | Antigenic binding patterns of norovirus to human histo-blood group antigens |
| AU2003273206B2 (en) * | 2002-05-31 | 2009-08-20 | Children's Hospital Medical Center | Method, composition and kit for antigenic binding of Norwalk-Like viruses |
| EP2272522B1 (de) * | 2002-06-28 | 2017-09-06 | Nestec S.A. | Therapeutische Zusammensetzungen zur Verwendung bei der Prophylaxe oder Behandlung von Diarrhö |
| KR20060030860A (ko) * | 2003-06-24 | 2006-04-11 | 유니버시티 오브 캔사스 메디컬 센터 | 유아 조제유 |
| WO2005055944A2 (en) * | 2003-12-05 | 2005-06-23 | Cincinnati Children's Hospital Medical Center | Oligosaccharide compositions and use thereof in the treatment of infection |
| ES1056525Y (es) * | 2004-01-13 | 2004-07-16 | Perez Alfredo Pineiro | Halador de tres rodillos para redes y aparejos de pesca. |
| DK1629850T4 (da) * | 2004-08-24 | 2013-07-01 | Nutricia Nv | Næringssammensætning indeholdende ufordøjelige oligosaccharider |
| WO2007090894A1 (en) * | 2006-02-10 | 2007-08-16 | Nestec S.A. | Oligosaccharide mixture |
| US20110152263A1 (en) * | 2006-11-16 | 2011-06-23 | Xi Jiang | Composition and method for inhibiting norovirus infection |
| US8197872B2 (en) * | 2007-05-17 | 2012-06-12 | The Regents Of The University Of California | Human milk oligosaccharides to promote growth of beneficial gut bacteria |
| MX2010002562A (es) | 2007-09-07 | 2011-04-11 | Inst Nac De Ciencias Medicas Y Nutricion | Uso de los niveles de antigeno secretor, de lewis y de sialilo como predictores para enfermedad. |
| EP2060257A1 (de) * | 2007-11-08 | 2009-05-20 | Nestec S.A. | Vorbeugung und Behandlung von Sekundärinfektionen nach Virusinfektion |
| MY159076A (en) * | 2007-11-08 | 2016-12-15 | Nestec Sa | Use of oligosaccharides containing n-acetyllactosamine for maturation of immune responses in neonates |
| EP2072052A1 (de) | 2007-12-17 | 2009-06-24 | Nestec S.A. | Verhinderung opportunistischer Infektionen bei Personen mit schwachem Immunsystem |
| EP2265135B1 (de) | 2008-03-14 | 2017-12-20 | Nestec S.A. | Synbiotische mischung |
| EP2370084B1 (de) * | 2008-12-02 | 2014-10-22 | Prolacta Bioscience, Inc. | Muttermilchpermeatzusammensetzungen sowie verfahren zu ihrer herstellung und verwendung |
| US9103821B2 (en) * | 2008-12-19 | 2015-08-11 | Momenta Pharmaceuticals, Inc. | Methods related to modified glycans |
| CN107043408B (zh) | 2009-06-09 | 2021-02-09 | 儿童医院医疗中心 | 抗原-诺罗病毒p-结构域单体和二聚体，抗原-诺罗病毒p-粒子分子，及其制备和应用方法 |
| JP2012532195A (ja) | 2009-07-06 | 2012-12-13 | チルドレンズ ホスピタル メディカル センター | 乳オリゴ糖による炎症の阻害 |
| CN107087793A (zh) * | 2009-07-15 | 2017-08-25 | N·V·努特里奇亚 | 用于刺激免疫系统的不可消化低聚糖的混合物 |
| WO2011136648A1 (en) | 2010-04-27 | 2011-11-03 | N.V. Nutricia | Use of human milk oligosaccharides in infant nutrition |
| WO2011136637A1 (en) | 2010-04-27 | 2011-11-03 | N.V. Nutricia | Use of human milk oligosaccharides in infant nutrition |
| EP2576578B1 (de) * | 2010-06-01 | 2018-09-19 | Glycom A/S | Polymorphe von 2'-o-fucosyllactose und herstellung davon |
| EP2454948A1 (de) | 2010-11-23 | 2012-05-23 | Nestec S.A. | Oligosaccharidmischung und Lebensmittel mit dieser Mischung, insbesondere Säuglingsnahrung |
| EP2465509A1 (de) | 2010-11-23 | 2012-06-20 | Nestec S.A. | Oligosaccharid Zusammensetzung zur Behandlung von akuten Atemwegsinfektionen |
| ES2804258T3 (es) | 2010-12-31 | 2021-02-05 | Abbott Lab | Procedimientos para reducir la incidencia de estrés oxidativo usando oligosacáridos de leche humana, vitamina C y agentes antiinflamatorios |
| EP3338784B1 (de) | 2010-12-31 | 2020-07-22 | Abbott Laboratories | Oligosaccharide aus muttermilch zur modulierung von entzündungen |
| NZ611807A (en) | 2010-12-31 | 2015-02-27 | Abbott Lab | Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides |
| DK2658399T4 (da) | 2010-12-31 | 2024-03-25 | Abbott Lab | Ernæringssammensætninger omfattende humane mælkeoligosaccharider til anvendelse i behandling og/eller forebyggelse af enterisk rotavirus-infektion |
| MX356184B (es) * | 2010-12-31 | 2018-05-17 | Abbott Lab | Fórmulación pediátrica sintética que comprende un probiótico. |
| BR112013016929A2 (pt) * | 2010-12-31 | 2019-09-24 | Abbott Lab | oligossacarídeos de leite humano para promover o crescimento de bactérias benéficas |
| MX388089B (es) | 2010-12-31 | 2025-03-19 | Abbott Lab | Metodos para usar los oligosacaridos de leche humana para mejorar la salud respiratoria de las vias aereas. |
| EP2658400A2 (de) | 2010-12-31 | 2013-11-06 | Abbott Laboratories | Nahrungsformulierungen mit menschlichen milcholigosacchariden und antioxidantien und verwendungen davon |
| JP6129821B2 (ja) | 2011-05-13 | 2017-05-17 | グリコシン リミテッド ライアビリティー カンパニー | プレバイオティクスとしての、精製された２’−フコシルラクトース、３−フコシルラクトース、およびラクトジフコテトラオースの使用 |
| EP2522232A1 (de) * | 2011-05-13 | 2012-11-14 | Nestec S.A. | Nahrungsmittel mit menschlichen Milcholigosacchariden und Herstellungsverfahren dafür |
| EP2526784A1 (de) | 2011-05-24 | 2012-11-28 | Nestec S.A. | Milcholigosaccharid-Galactooligosaccharid-Zusammensetzung für Kindernahrung mit niedrigem Monosaccharidgehalt, enthaltend die in der Milch vorhandene lösliche Oligosaccharidfraktion, sowie ein Verfahren zur Herstellung der Zusammensetzung |
| DK2734210T3 (en) * | 2011-07-22 | 2018-01-22 | Abbott Lab | GALACTOOLIGOSACCHARIDES FOR THE PREVENTION OF DAMAGE TO AND / OR PROMOTION OF HEALING OF THE MAVE GAS CHANNEL |
| US10639319B2 (en) * | 2011-08-29 | 2020-05-05 | Abbott Laboratories | Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract |
| US9834574B2 (en) * | 2012-11-13 | 2017-12-05 | Glycom A/S | Crystalline 3-O-fucosyllactose |
| WO2014090261A1 (en) * | 2012-12-14 | 2014-06-19 | Glycom A/S | Mixture of fucosylate lactoses |
| EP2745705A1 (de) * | 2012-12-18 | 2014-06-25 | Abbott Laboratories | Ernährungsbedingte Verwendung von Muttermilch Oligosacchariden |
| US10626460B2 (en) | 2013-02-21 | 2020-04-21 | Children's Hospital Medical Center | Use of glycans and glycosyltransferases for diagnosing/monitoring inflammatory bowel disease |
| DK2999358T3 (en) | 2013-05-22 | 2021-10-11 | Glycom As | Synthetic mixture of oligosaccharides for the treating a microbiota of a mammal |
| US9321803B2 (en) | 2013-07-12 | 2016-04-26 | Children's Hospital Medical Center | Compositions and methods for inhibiting norovirus infection |
| ES2856013T3 (es) | 2013-11-15 | 2021-09-27 | Nestle Sa | Composiciones para su uso en la prevención o tratamiento de infecciones del TRS en bebés o niños jóvenes en riesgo |
| HK1231398A1 (zh) | 2014-04-08 | 2017-12-22 | Abbott Laboratories | 使用人乳寡糖增强对病原体的粘膜先天免疫反应和/或检测的方法 |
| AU2015323762A1 (en) | 2014-09-25 | 2017-02-16 | Société des Produits Nestlé S.A. | Infant formula system with adaptive levels of human milk oligosaccharides (HMOs) |
| CN107108677B (zh) | 2014-10-24 | 2020-08-07 | 格礼卡姆股份公司 | Hmo的混合物 |
| MY182925A (en) | 2014-10-31 | 2021-02-05 | Nestle Sa | Composition comprising fut2-dependent oligosaccharides and lacto-n-neotetraose for use in promoting brain development and cognition |
| MX380540B (es) * | 2015-03-05 | 2025-03-12 | Soc Des Produits Nestle S A Star | Composiciones para uso en la prevención o el tratamiento de otitis o bronquitis en infantes o niños pequeños. |
| MX378680B (es) | 2015-03-05 | 2025-03-11 | Soc Des Produits Nestle S A Star | Composiciones para usar en la prevencion o el tratamiento de infecciones/inflamaciones gastrointestinales en infantes o niños pequeños. |
| US10857167B2 (en) | 2015-04-28 | 2020-12-08 | Children's Hospital Medical Center | Use of oligosaccharide compositions to enhance weight gain |
| EP3331534B1 (de) * | 2015-08-04 | 2019-12-18 | Société des Produits Nestlé S.A. | Nährstoffzusammensetzung mit 2fl und lnnt zum induzieren einer darmbiozönose in der nähe gestillter kleinkinder |
| CN108541221B (zh) | 2015-12-15 | 2023-02-28 | 格礼卡姆股份公司 | Hmo的混合物 |
| WO2017129646A1 (en) * | 2016-01-26 | 2017-08-03 | Nestec S.A. | Human milk oligosaccharides against later in life excessive fat mass accumulation and related health disorders |
| MX382373B (es) * | 2016-01-26 | 2025-03-13 | Soc Des Produits Nestle S A Star | Oligosacáridos de la leche humana para beneficios de la salud mediante la prevención del rebote adiposo precoz. |
| KR102593408B1 (ko) * | 2016-09-19 | 2023-10-25 | 프롤랙타 바이오사이언스, 인코포레이티드 | 정제된 인간 모유 올리고당 조성물 |
| US20180103675A1 (en) | 2016-10-14 | 2018-04-19 | Mead Johnson Nutrition Company | Personalized pediatric nutrition products comprising human milk oligosaccharides |
| US10980269B2 (en) * | 2016-12-12 | 2021-04-20 | Mead Johnson Nutrition Company | Protein hydrolysates and methods of making same |
| US11833198B2 (en) | 2017-03-28 | 2023-12-05 | Children's Hospital Medical Center | Norovirus S particle based vaccines and methods of making and using same |
| MX2019011334A (es) | 2017-05-24 | 2019-10-30 | Nestle Sa | Composicion que comprende oligofructosa (of) para usar en la mejora de la memoria a corto plazo y otros beneficios congnitivos. |
| AU2018274636B2 (en) | 2017-05-24 | 2024-05-02 | Societe Des Produits Nestle S.A. | Composition comprising Human Milk Oligosaccharides (HMO) for use in the improvement of short term memory and other cognitive benefits |
| US20200221749A1 (en) | 2017-07-07 | 2020-07-16 | Societe Des Produits Nestle S.A. | Human milk fortifier |
| US12628859B2 (en) | 2017-07-07 | 2026-05-19 | Societe Des Produits Nestle S.A. | Human milk fortifier |
| EP3648617A1 (de) * | 2017-07-07 | 2020-05-13 | Société des Produits Nestlé S.A. | Verstärker für muttermilch |
| US11197917B2 (en) | 2017-12-01 | 2021-12-14 | ByHeart, Inc. | Formulations for nutritional support in subjects in need thereof |
| DK3524067T3 (da) | 2018-02-08 | 2025-05-19 | Chr Hansen Hmo Gmbh | Spraytørret blanding af modermælksoligosaccharider |
| WO2019160922A1 (en) * | 2018-02-19 | 2019-08-22 | Dupont Nutrition Biosciences Aps | Process for spray drying fucosyllactose solutions and related product compositions |
| EP3546060A1 (de) * | 2018-03-27 | 2019-10-02 | DuPont Nutrition Biosciences ApS | Verfahren zur sprühtrocknung von fucosyllactoselösungen und verwandte produktzusammensetzungen |
| WO2020001862A1 (en) | 2018-06-25 | 2020-01-02 | Societe Des Produits Nestle S.A. | Composition comprising human milk oligosaccharides for use in improving, enhancing, promoting or modulating a serotonergic function in the central nervous system |
| AU2019296553B2 (en) | 2018-06-25 | 2024-10-10 | Societe Des Produits Nestle S.A. | Composition comprising human milk oligosaccharides for use in improving, enhancing, promoting or modulating a gabaergic function in the central nervous system |
| WO2020127161A1 (en) * | 2018-12-20 | 2020-06-25 | Société des Produits Nestlé S.A. | Human milk fortifier composition |
| EP3934656A1 (de) * | 2019-03-05 | 2022-01-12 | Société des Produits Nestlé S.A. | Ernährungszusammensetzung zur verwendung zur verbesserung einer ausführungsfunktion |
| PL3979827T3 (pl) * | 2019-06-04 | 2024-01-15 | N.V. Nutricia | Kompozycja żywieniowa zawierająca 2'fukozylolaktozę i 3'galaktozylolaktozę |
| WO2021015977A1 (en) * | 2019-07-23 | 2021-01-28 | Dupont Nutrition Biosciences Aps | Oral healthcare treatment and related compositions |
| ES1240969Y (es) * | 2019-09-18 | 2020-07-30 | Jennewein Biotechnologie Gmbh | Composiciones de cereales que contienen oligosacaridos de la leche humana |
| AU2020354581A1 (en) | 2019-09-24 | 2022-03-03 | Prolacta Bioscience, Inc. | Compositions and methods for treatment of inflammatory and immune diseases |
| GB2590375B (en) * | 2019-12-11 | 2024-05-08 | Mjn Us Holdings Llc | Staged nutritional compositions containing human milk oligosaccharides and uses thereof |
| TW202233201A (zh) * | 2020-12-16 | 2022-09-01 | 荷蘭商弗里斯蘭康必奶荷蘭有限公司 | 包含ＬＮＦＰ ＩＩＩ和ＬＳＴａ的合成組成物 |
| PL4346450T3 (pl) | 2021-06-04 | 2025-06-09 | N.V. Nutricia | Preparat do początkowego żywienia niemowląt do żywienia niemowląt otrzymujących preparat do początkowego żywienia niemowląt i mleko kobiece |
| WO2026125457A1 (en) * | 2024-12-10 | 2026-06-18 | Société des Produits Nestlé S.A. | Human milk oligosaccharides and combinations for enhancing bone quality |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5951264B2 (ja) * | 1981-11-30 | 1984-12-13 | 雪印乳業株式会社 | オリゴ糖含有粉末の製造方法 |
| DD273543A3 (de) * | 1987-09-14 | 1989-11-22 | Univ Rostock | Verfahren zur herstellung von saeuglings- und diaetnahrungen mit hypoantigener, bifidogener wirkung |
| SE462134B (sv) * | 1987-10-22 | 1990-05-14 | Biocarb Ab | Livsmedel innehaallande lacto-n-tetraos och foerfarande foer dess framstaellning |
| DE3876986D1 (de) * | 1988-07-07 | 1993-02-04 | Milupa Ag | Verfahren zur enzymatischen herstellung von bifidogener saeuglings- und diaetnahrung. |
| US5095106A (en) * | 1989-07-25 | 1992-03-10 | Colgate-Palmolive | Olgiosaccharide inhibition of Streptococcus pyogenes adhesion |
| WO1991016449A1 (en) * | 1990-04-16 | 1991-10-31 | The Trustees Of The University Of Pennsylvania | Saccharide compositions, methods and apparatus for their synthesis |
| US5021245A (en) * | 1990-05-22 | 1991-06-04 | Abbott Laboratories | Infant formula containing a soy polysaccharide fiber source |
| CN1129953A (zh) * | 1993-07-15 | 1996-08-28 | 尼奥斯药品公司 | 糖组分的合成方法 |
| US5750176A (en) * | 1994-03-09 | 1998-05-12 | Abbott Laboratories | Transgenic non-human mammal milk comprising 2'-fucosyl-lactose |
| JPH0838064A (ja) * | 1994-07-26 | 1996-02-13 | Meiji Seika Kaisha Ltd | 有害細菌の感染を予防する飼料 |
| US5545553A (en) * | 1994-09-26 | 1996-08-13 | The Rockefeller University | Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
| US5827526A (en) * | 1995-07-11 | 1998-10-27 | Abbott Laboratories | Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans |
-
1997
- 1997-03-31 US US08/829,157 patent/US6045854A/en not_active Expired - Lifetime
-
1998
- 1998-03-30 ES ES98912118.1T patent/ES2265161T5/es not_active Expired - Lifetime
- 1998-03-30 AT AT98912118T patent/ATE326862T1/de active
- 1998-03-30 EP EP98912118.1A patent/EP0975235B2/de not_active Expired - Lifetime
- 1998-03-30 WO PCT/US1998/006216 patent/WO1998043494A1/en not_active Ceased
- 1998-03-30 DK DK98912118.1T patent/DK0975235T4/da active
- 1998-03-30 DE DE69834633.5T patent/DE69834633T3/de not_active Expired - Lifetime
- 1998-03-30 JP JP54189298A patent/JP4863236B2/ja not_active Expired - Fee Related
- 1998-03-30 PT PT98912118T patent/PT975235E/pt unknown
- 1998-03-30 CA CA2285065A patent/CA2285065C/en not_active Expired - Lifetime
- 1998-12-18 US US09/216,056 patent/US6146670A/en not_active Expired - Lifetime
-
1999
- 1999-09-23 NO NO19994621A patent/NO315682B1/no not_active IP Right Cessation
- 1999-09-29 MX MX9908953A patent/MX210206B/es unknown
-
2011
- 2011-09-07 JP JP2011195159A patent/JP2012036192A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| EP0975235B1 (de) | 2006-05-24 |
| DK0975235T4 (da) | 2014-03-31 |
| ES2265161T5 (es) | 2014-03-24 |
| US6146670A (en) | 2000-11-14 |
| ES2265161T3 (es) | 2007-02-01 |
| NO994621D0 (no) | 1999-09-23 |
| NO994621L (no) | 1999-09-23 |
| CA2285065C (en) | 2011-07-19 |
| JP2012036192A (ja) | 2012-02-23 |
| JP2001517949A (ja) | 2001-10-09 |
| NO315682B1 (no) | 2003-10-13 |
| US6045854A (en) | 2000-04-04 |
| DK0975235T3 (da) | 2006-10-02 |
| DE69834633T2 (de) | 2007-05-03 |
| CA2285065A1 (en) | 1998-10-08 |
| MX9908953A (es) | 2000-01-31 |
| EP0975235A1 (de) | 2000-02-02 |
| DE69834633D1 (de) | 2006-06-29 |
| WO1998043494A1 (en) | 1998-10-08 |
| EP0975235B2 (de) | 2014-01-15 |
| JP4863236B2 (ja) | 2012-01-25 |
| MX210206B (es) | 2002-09-06 |
| PT975235E (pt) | 2006-10-31 |
| DE69834633T3 (de) | 2014-05-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK0975235T3 (da) | Ernæringssammensætninger indeholdende oligosaccharider | |
| IL118047A (en) | Sulfated oligosaccharides pharmaceutical compositions containing them and preparation of sulfated hexopyranose homooligosaccharides | |
| NO20001105L (no) | Transgene pattedyr som danner oligosakkarider i melken | |
| PE44895A1 (es) | Compuesto derivado de benzotiofeno que puede inhibir la perdida osea y disminuir el colesterol en suero | |
| BR9611362A (pt) | Composicões detergentes | |
| YU23599A (sh) | Stabilizovani antihistaminski sirup | |
| TNSN91070A1 (fr) | Procede de preparation de derives de benzofuranne, bentothiophene indole ou indolizine ainsi que des compositions les contenant. | |
| PL347671A1 (en) | Compounds and compositions for delivering active agents | |
| NO20022751L (no) | Basisforbindelse med forbedret proteininnhold | |
| NZ516290A (en) | Substituted phenoxyacetic acids | |
| PT1058544E (pt) | Inibicao da actividade do tnf | |
| HUP9801133A3 (en) | 1,2,4-triazole-derivatives, fungicide compositions containing these compounds as active ingredients | |
| BG103306A (en) | Liquid allendronate compositions | |
| EP1075796A4 (de) | Suesstoffzusammensetzung | |
| EP1121932A4 (de) | Heilmittel für augenerkrankungen | |
| ES2183346T3 (es) | Sistemas conjugados de bis-fosfonato con restos alquilantes que tienen actividad antitumoral. | |
| BG103779A (en) | Crystallohydrate sodium salt of (e)-4,6-dichloro-3-(2-oxo-1-phenylpyrrolidine-3-ilidenmethyl)-1h-i ndole-2-carboxylic acid | |
| AU7365596A (en) | Nisin compositions to prevent the promotion of tooth decay bysuppressing formation of acid from foods by oral bacteria | |
| GB2314507A (en) | Anti-emetic pharmaceutical compositions containing methotrimeprazine | |
| CA2183745A1 (en) | Detergent Compositions | |
| MX9503625A (es) | Metodo para reducir el daño por radicales libres en celulas de mamiferos vivos. | |
| IT1254324B (it) | Soluzioni campione di cianuro stabili all'immagazzinamento |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0975235 Country of ref document: EP |